BJU Int 2011 Oct
Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma with severe renal impairment or on haemodialysis.
Related Questions
New answer by Medical Oncologist at Johns Hopkins Medicine (February 13, 2021)
For patients with ESRD on dialysis, prior data showed that pharmacokinetics of VEGF-TKIs in subjects with severe renal impairment were similar to those with normal renal funct...